Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Getting To Grips With International Reference Pricing

Executive Summary

International reference pricing has become something of a fixture as payers around the world grapple with rising healthcare costs. The landscape is becoming more complex as the practice spreads further into emerging markets, reference baskets get bigger, and calls for pricing transparency grow louder. Scrip examines some of the problems companies face and some of the ways they can adapt, including through new technology, revised approaches to launching new products and better relations with stakeholders.

You may also be interested in...



Manufacturing Incentives, Flexible Regulations Seen As Remedy For EU Drug Shortages

A committee of influential politicians in Europe are calling for measures that will see the EU become more self-sufficient in the production of medicines, thereby reducing medicine shortages and dependence on imports from third countries.

Patients Call For EU-Level Differential Pricing

In a “strengthened call to action” to improve access to medicines, the European Patients Forum says an EU-level reflection on differential pricing is needed and that patients should to be more central to designing R&D.

EU Pharmaceutical Strategy Roadmap Seen As Weak On Innovation

Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.

Topics

Related Companies

UsernamePublicRestriction

Register

LL1126271

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel